GREENHEART GP (00094) issues a profit warning, expecting a net loss reduction of no less than 45% year-on-year in 2025.
Greenheart Group (00094) announced that the group expects the net loss for 2025 to decrease by not less than 45% year-on-year. The decrease in net loss attributable to shareholders is mainly due to the comprehensive impact of the following items: fair value gains related to assets in artificial forests in New Zealand amounted to approximately HK$35.4 million (2024: loss of HK$65.8 million); costs related to the sale of assets in artificial forests and land in New Zealand recognized in a very significant sale transaction amounted to approximately HK$2.6 million (2024: nil); and a loss of approximately HK$88.8 million (2024: HK$73.8 million) due to the termination of operations at the Suriname branch.
GREENHEART GP (00094) announced that the group expects a net loss reduction of not less than 45% compared to 2025. The main reasons for the decrease in net loss attributable to shareholders are the comprehensive impact of the following items: fair value gain of approximately HK$35.4 million related to artificial forest assets in New Zealand (2024: loss of HK$65.8 million); costs related to the sale of artificial forest assets and land in New Zealand of approximately HK$2.6 million recognized in significant disposal events during the period (2024: none); and a loss of approximately HK$88.8 million (2024: HK$73.8 million) due to the termination of operations in the Suriname division.
The Suriname division has consistently achieved negative results in previous years, and despite management's ongoing efforts to improve its operations and performance, the value of assets has significantly decreased over the years. In order to improve financial sustainability and allow management to focus resources on other businesses within the group, the group sold most of its loss-making subsidiaries in Suriname this year, followed by the termination of operations in Suriname. The above sale was made to independent third parties, and the proceeds from the sale were negligible.
Related Articles

JNBY (03306) will distribute a mid-year dividend of HK$0.52 per share on April 15th.

BEONE MEDICINES (06160) expects strong growth in performance in 2025, with adjusted net profit of approximately 918 million US dollars, turning losses into profits year-on-year.

JS GLOBAL LIFE (01691) issues profit warning, expecting a net loss of no more than 22.5 million US dollars for the fiscal year 2025.
JNBY (03306) will distribute a mid-year dividend of HK$0.52 per share on April 15th.

BEONE MEDICINES (06160) expects strong growth in performance in 2025, with adjusted net profit of approximately 918 million US dollars, turning losses into profits year-on-year.

JS GLOBAL LIFE (01691) issues profit warning, expecting a net loss of no more than 22.5 million US dollars for the fiscal year 2025.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


